Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Merck Co MRK HIV Treatment Approval Offsets Mixed Oncology Pipeline Updates At ASCO ZCMD Zhongchao plans targeted investments in core health service lines to boost long term operational performance Is KimberlyClark Corporation KMB stock still attractive Q4 2025 Profit Exceeds Views BorgWarner BWA Stock Movement Analysis Q4 2025 Profit Exceeds Views GoPro GPRO Stock Trendline Structure Pulls Back 20260420 The one metric that defines NACCO Industries NC success Momentum Building 20260506 iShares Core MSCI Emerging Markets ETF IEMG Comparative Performance Strategic Fit Against Peer SPGM Pfizer Inc PFE Strategic CDK Inhibitor Supply Partnership with Relay Therapeutics Validates Atirmociclib Commercial Potential in Metastatic Breast Cancer Grayscale Bitcoin Trust ETF GBTC Positioning Amid Bitcoins 71000 Price Floor and Maturing Spot ETF Ecosystem Tariffs Fail to Deliver Economic Gains Tax Foundation Analysis Finds BYD in Talks to Acquire Idle European Plants Targeting Maserati Expansion Helen of HELE Stock Analysis 171 Gain What to Watch 20260519 Citizens CIA Stock Analysis 402 Loss Key Levels 20260518 GlobalFoundries GFS Q1 2026 Earnings Strong EPS Beat Fuels DoubleDigit Stock Surge Harvard Faculty Votes to Restore Grade Integrity Signaling Shift in Academic Standards Liberty LBRDP Q3 2025 Earnings Surge EPS 177 vs 127 Forecast Xi Warns Trump Mishandling Taiwan Could Trigger Clashes and Even Conflicts in USChina Relations NXE Q1 2026 Earnings EPS Misses Estimates Significantly as Stock Gains on LongTerm Outlook EGP Q1 2026 Earnings Strong EPS Beat Driven by Solid Operations ENIC Q4 2025 Earnings EPS Surpasses Estimates Amid Operational Resilience Enpro Inc NPO Q1 2026 Earnings EPS Beat Drives Positive Stock Reaction BW Q1 2026 Earnings Significant EPS Miss Sends Shares Lower iHeartMedia Shares Edge Lower as IHRT Tests Support at 453 Jazz Pharmaceuticals Holds Steady Near Key Levels Amid Modest Gains Immunic Inc IMUX Rally Continues with 879 Gain Approaching Key Resistance Coherus Oncology CHRS Rises 37 as Stock Approaches Resistance at 178